目的:评估诊断为缓解CSC的患者的临床和功能后遗症,通过黄斑OCT,对比敏感度试验,视野10-2和FarnsworthD-15颜色测试。
方法:纳入并评估了26例通过黄斑OCT解决的CSC患者的27只眼;患者使用Optec6500设备进行了对比敏感度测试,10-2视野与章鱼900Haag-Streit,还有FarnsworthD-15颜色测试.
结果:通过黄斑OCT观察到20眼(74.1%)的后遗症,对比敏感度为21眼(77.8%),主要是2型缺陷。另外27(100%)的视野10-2改变,对应于中央凹敏感度降低,11只眼(40.7%)对应于中央和中央旁暗点。颜色测试显示11只(40.7%)被评估的眼睛有改变,在其中9例(81.8%)中发现了tritabrase。观察组与治疗组之间的研究没有显着差异。
结论:CSC尽管在急性期进行了治疗,但仍可能在患者的视觉质量上留下后遗症。干预组治疗前后视力差异无统计学意义。
OBJECTIVE: To evaluate the clinical and functional sequelae of patients with a diagnosis of resolved CSC, through macular OCT, contrast sensitivity test, visual field 10-2 and Farnsworth D-15 color test.
METHODS: 27 eyes of 26 individuals with CSC resolved by macular OCT were included and evaluated; the patients underwent a contrast sensitivity test with the Optec 6500 equipment, a 10-2 visual field with an Octopus 900 Haag-Streit, and a Farnsworth D-15 color test.
RESULTS: Sequelae were observed in 20 eyes (74.1%) by macular OCT and in 21 (77.8%) in contrast sensitivity, predominantly type 2 defect. Also 27 (100%) had a visual field 10-2 altered corresponding to reduced foveal sensitivity, 11 eyes (40.7%) corresponded to central and paracentral scotomas. The color test showed alteration in 11 (40.7%) of the total eyes evaluated, finding tritanomaly in 9 of them (81.8%). No significant differences were observed in the studies between observation group vs the treatment group.
CONCLUSIONS: CSC can leave sequelae in the visual quality of patients despite treatment in the acute phase. Visual acuity before and after treatment in the intervention group had no significant difference.